Tempus AI, Inc.
For the period ended Sep 30, 2026. Filed Nov 2, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 2, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations and Comprehensive Loss
(in thousands, except per share amounts)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Net revenue | ||||
| Diagnostics(1) | $303,470 | $252,878 | $853,901 | $688,525 |
| Data and applications(2) | 108,067 | 81,328 | 288,238 | 216,053 |
| Total net revenue | $411,537 | $334,206 | $1,142,139 | $904,578 |
| Cost and operating expenses | ||||
| Cost of revenues, diagnostics | 114,042 | 98,643 | 323,235 | 283,182 |
| Cost of revenues, data and applications | 30,794 | 25,621 | 83,664 | 61,212 |
| Technology research and development | 45,708 | 38,087 | 135,558 | 105,960 |
| Research and development | 46,000 | 44,960 | 146,874 | 122,453 |
| Selling, general and administrative | 231,857 | 187,891 | 670,296 | 523,230 |
| Total cost and operating expenses | 468,401 | 395,202 | 1,359,627 | 1,096,037 |
| Loss from operations | $(56,864) | $(60,996) | $(217,488) | $(191,459) |
| Interest income | 3,985 | 4,600 | 11,748 | 7,506 |
| Interest expense | (6,701) | (15,399) | (31,325) | (54,981) |
| Loss on debt extinguishment | — | (12,034) | (11,643) | (12,034) |
| Other income, net(3) | 47,132 | 2,605 | 122,180 | 16,879 |
| Loss before (provision for) benefit from income taxes | $(12,448) | $(81,224) | $(126,528) | $(234,089) |
| (Provision for) benefit from income taxes | (35) | (276) | (282) | 45,692 |
| (Losses) gains from equity method investments | (2,368) | 1,518 | (8,318) | (2,465) |
| Net loss | $(14,851) | $(79,982) | $(135,128) | $(190,862) |
| Net loss per share, basic and diluted | $(0.08) | $(0.46) | $(0.75) | $(1.10) |
| Weighted-average shares outstanding used to compute net loss per share, basic and diluted | 181,311 | 174,945 | 180,049 | 172,969 |
| Comprehensive loss, net of tax | ||||
| Net loss | $(14,851) | $(79,982) | $(135,128) | $(190,862) |
| Foreign currency translation adjustment | 2,107 | (2,915) | (736) | 5,439 |
| Comprehensive loss | $(12,744) | $(82,897) | $(135,864) | $(185,423) |
(1) Includes related party revenue from Pathos AI, Inc. of $0 and $225 for the three months ended September 30, 2026 and 2025, respectively. Includes related party revenue from Pathos AI, Inc. of $190 and $226 for the nine months ended September 30, 2026 and 2025, respectively. Refer to Note 16, Related Parties.
(2) Includes related party revenue from Pathos AI, Inc. of $22,061 and $24,907 for the three months ended September 30, 2026 and 2025, respectively. Includes related party revenue from Pathos AI, Inc. of $65,718 and $41,445 for thenine months ended September 30, 2026 and 2025, respectively. Refer to Note 16, Related Parties. Also includes related party revenue from SB Tempus Corp. of $0 and $6,253 for thethree months ended September 30, 2026 and 2025, respectively. Includes related party revenue from SB Tempus Corp. of $6,241 and $18,743 for thenine months ended September 30, 2026 and 2025, respectively. Refer to Note 7, Joint Venture.
(3)Includes related party other income from SB Tempus Corp. of $3,989 for each of thethree months ended September 30, 2026 and 2025. Includes related party other income from SB Tempus Corp. of $11,966 for each of thenine months ended September 30, 2026 and 2025. Refer to Note 7, Joint Venture.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.